Skip to content

The effect of diaphragmatic breathing in reducing anxiety in patients undergoing treatment for crime.

Studying the effect of diaphragmatic breathing (deep breathing) in reducing anxiety in patients undergoing scaling and root planing treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230615058492N4
Enrollment
60
Registered
2026-05-05
Start date
2026-05-29
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with periodontitis. Gingivitis and periodontal diseases

Interventions

Intervention 1: Intervention group: In this group, patients are taught diaphragmatic breathing and during treatment, patients are asked to perform diaphragmatic breathing. Intervention 2: Control gro

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: Age between 20 and 55 years Need for scaling treatment (with accumulation of local factors and development of Stage II-IV periodontitis) No previous experience with root canal treatment and root planing

Exclusion criteria

Exclusion criteria: Not having heart or lung disease such as asthma No smoking No diagnosed mental health problems such as anxiety and depression Not taking anti-anxiety medications Not pregnant or breastfeeding Not receiving chemotherapy; receiving painkillers; taking anti-anxiety or antidepressant medications; taking medications that affect heart rate and blood pressure, such as diuretics and beta-blockers; taking anticonvulsants; using immunosuppressant medications; or receiving local anesthesia during treatment

Design outcomes

Primary

MeasureTime frame
Mental anxiety. Timepoint: Before the intervention, after two-thirds of the treatment. Method of measurement: Spielberger’s State-Trait Anxiety Inventory–State Scale.

Secondary

MeasureTime frame
Heart rate. Timepoint: Before starting treatment, after completing two-thirds of the treatment. Method of measurement: Pulse oximeter device.;Blood oxygen. Timepoint: Before starting treatment, after completing two-thirds of the treatment. Method of measurement: Pulse oximeter device.;Systolic blood pressure. Timepoint: Before starting treatment, after completing two-thirds of the treatment. Method of measurement: Digital sphygmomanometer.;Diastolic blood pressure. Timepoint: Before starting treatment, after completing two-thirds of the treatment. Method of measurement: Digital sphygmomanometer.;Satisfaction from treatment. Timepoint: Immediately after treatment. Method of measurement: Ask questions in the questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Zare Mehrjardi

Yazd University of Medical Sciences

zahrazare3362@gmail.com+98 35 3625 5881

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026